期刊
CANCER BIOMARKERS
卷 6, 期 1, 页码 21-32出版社
IOS PRESS
DOI: 10.3233/CBM-2009-0116
关键词
Tumour therapy; cancer; diffusion; bone; magnetic resonance imaging
类别
资金
- CRUK
- EPSRC Cancer Imaging Centre
- Department of Health (England) [C1060/A10334]
- NHS
- NIHR Biomedical Research Centre
Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) combined with conventional MRI can provide a whole body assessment of metastatic bone disease, improved lesion detection compared to other imaging techniques and a direct quantitative assessment of treatment response. In bone marrow, the presence of fat and bone trabeculae and their changing contributions with disease progression and response to treatment present unique challenges for data acquisition and image interpretation. This article discusses these challenges and reviews the potential of DW-MRI to provide a biomarker of response in metastatic bone disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据